indomethacin has been researched along with Tension-Type Headache in 6 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Tension-Type Headache: A common primary headache disorder, characterized by a dull, non-pulsatile, diffuse, band-like (or vice-like) PAIN of mild to moderate intensity in the HEAD; SCALP; or NECK. The subtypes are classified by frequency and severity of symptoms. There is no clear cause even though it has been associated with MUSCLE CONTRACTION and stress. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
Excerpt | Relevance | Reference |
---|---|---|
"In this double-blind, randomized, parallel group, multicentre study the efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine (IndoProCaf) and nimesulide were compared over an 8-h period in the treatment of two consecutive episodes of tension-type headache (TTH)." | 9.11 | Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial. ( Centonze, V; Cerbo, R; Grazioli, I; Sternieri, E; Tavolato, B; Trenti, T; Uslenghi, C, 2005) |
"The majority of previous studies on unilateral headaches beyond migraine and cluster headache have focussed on certain disorders such as paroxysmal hemicrania, SUNCT and primary stabbing headache." | 5.37 | Clinical features of unilateral headaches beyond migraine and cluster headache and their response to indomethacin. ( Lieba-Samal, D; Seidel, S; Vigl, M; Wöber, C, 2011) |
"In this double-blind, randomized, parallel group, multicentre study the efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine (IndoProCaf) and nimesulide were compared over an 8-h period in the treatment of two consecutive episodes of tension-type headache (TTH)." | 5.11 | Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial. ( Centonze, V; Cerbo, R; Grazioli, I; Sternieri, E; Tavolato, B; Trenti, T; Uslenghi, C, 2005) |
"The TACs include cluster headache, paroxysmal hemicrania, and short-lasting neuralgiform headache attacks with conjunctival injection and tearing; hemicrania continua, although classified separately by the International Headache Society, shares many features of both migraine and the TACs." | 2.49 | Primary headache disorders. ( Benoliel, R; Eliav, E, 2013) |
"Primary stabbing headache (PSH) is defined by the presence of short stabbing pains in the first branch of the trigeminal nerve." | 1.38 | [Primary stabbing headache: clinical characteristics and response to treatment in a series of 67 patients]. ( Barón, J; Fernández-Buey, MN; Guerrero-Peral, ÁL; Herrero-Velázquez, S; Marco-Llorente, J; Mulero, P; Pedraza, MI; Ruiz, M, 2012) |
"The majority of previous studies on unilateral headaches beyond migraine and cluster headache have focussed on certain disorders such as paroxysmal hemicrania, SUNCT and primary stabbing headache." | 1.37 | Clinical features of unilateral headaches beyond migraine and cluster headache and their response to indomethacin. ( Lieba-Samal, D; Seidel, S; Vigl, M; Wöber, C, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Frediani, F | 1 |
Bussone, G | 1 |
Benoliel, R | 1 |
Eliav, E | 1 |
Hoy, SM | 1 |
Scott, LJ | 1 |
Seidel, S | 1 |
Lieba-Samal, D | 1 |
Vigl, M | 1 |
Wöber, C | 1 |
Pedraza, MI | 1 |
Guerrero-Peral, ÁL | 1 |
Herrero-Velázquez, S | 1 |
Mulero, P | 1 |
Barón, J | 1 |
Ruiz, M | 1 |
Marco-Llorente, J | 1 |
Fernández-Buey, MN | 1 |
Cerbo, R | 1 |
Centonze, V | 1 |
Grazioli, I | 1 |
Tavolato, B | 1 |
Trenti, T | 1 |
Uslenghi, C | 1 |
Sternieri, E | 1 |
3 reviews available for indomethacin and Tension-Type Headache
Article | Year |
---|---|
Primaries non-migraine headaches treatment: a review.
Topics: Cluster Headache; Headache; Humans; Indomethacin; Migraine Disorders; Tension-Type Headache | 2020 |
Primary headache disorders.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anticonvulsants; Chronic Disease; Cluster Headache; Cycloox | 2013 |
Indomethacin/prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Caffeine; Central Nervous System Stimul | 2011 |
1 trial available for indomethacin and Tension-Type Headache
Article | Year |
---|---|
Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Caffeine; | 2005 |
2 other studies available for indomethacin and Tension-Type Headache
Article | Year |
---|---|
Clinical features of unilateral headaches beyond migraine and cluster headache and their response to indomethacin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Ster | 2011 |
[Primary stabbing headache: clinical characteristics and response to treatment in a series of 67 patients].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Child | 2012 |